| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO and Interim CEO
1 company
Smith Hunter C serves as a Chief Financial Officer at RYTM. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Smith Hunter C's trades have earned a below-average insider score of 38/100 across 25 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -61.6%.
The biggest single holding is RYTM (~$2.9M) as Chief Financial Officer. The recent filings there lean toward selling, a net 263,504 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 62,774 | $105.46 | $6,619,913.40 | -35.5% | - | - | |
| Feb 19, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 7,954 | $101.31 | $805,813.76 | -6.7% | -12.1% | - | |
| Feb 12, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 7,071 | $100.21 | $708,575.59 | -5.6% | -2.4% | - | |
| Feb 5, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 6,628 | $106.03 | $702,744.16 | -5.0% | -7.0% | - | |
| Aug 13, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 28,088 | $96.29 | $2,704,623.77 | -19.4% | +2.0% | +18.6% | |
| Jul 9, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 42,120 | $80.48 | $3,389,756.13 | -26.5% | +12.2% | +29.8% | |
| May 30, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 23,400 | $61.41 | $1,437,010.37 | -17.6% | +69.9% | +44.0% | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 2,215 | $57.22 | $126,742.30 | -2.0% | +10.1% | +77.9% | |
| Feb 12, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 751 | $56.39 | $42,346.85 | -0.7% | -1.5% | +66.7% | |
| Feb 11, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 1,296 | $57.51 | $74,533.06 | -1.2% | +2.4% | +71.0% |